EP Patent

EP2997030B1 — Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors

Assigned to Nerviano Medical Sciences SRL · Expires 2017-08-09 · 9y expired

What this patent protects

Patent listed against larotrectinib-sulfate.

Drugs covered by this patent

Patent Metadata

Patent number
EP2997030B1
Jurisdiction
EP
Classification
—
Expires
2017-08-09
Drug substance claim
No
Drug product claim
No
Assignee
Nerviano Medical Sciences SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.